A detailed history of Wells Fargo & Company transactions in 23and Me Holding Co. stock. As of the latest transaction made, Wells Fargo & Company holds 18,184 shares of ME stock, worth $59,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,184
Previous 24,824 26.75%
Holding current value
$59,279
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.29 - $0.51 $1,925 - $3,386
-6,640 Reduced 26.75%
18,184 $6,000
Q2 2024

Aug 13, 2024

SELL
$0.36 - $0.61 $39,991 - $67,763
-111,088 Reduced 81.74%
24,824 $9,000
Q1 2024

May 10, 2024

BUY
$0.4 - $0.91 $10,635 - $24,195
26,588 Added 24.32%
135,912 $72,000
Q4 2023

Feb 09, 2024

BUY
$0.71 - $0.97 $12,410 - $16,955
17,480 Added 19.03%
109,324 $99,000
Q3 2023

Nov 13, 2023

SELL
$0.96 - $2.01 $32,829 - $68,735
-34,197 Reduced 27.13%
91,844 $90,000
Q2 2023

Aug 15, 2023

SELL
$1.59 - $2.29 $95,772 - $137,935
-60,234 Reduced 32.34%
126,041 $220,000
Q1 2023

May 12, 2023

BUY
$2.05 - $2.87 $15,362 - $21,507
7,494 Added 4.19%
186,275 $424,000
Q4 2022

Feb 13, 2023

SELL
$2.06 - $3.47 $47,689 - $80,330
-23,150 Reduced 11.46%
178,781 $386,000
Q3 2022

Nov 14, 2022

SELL
$2.6 - $5.12 $80,691 - $158,899
-31,035 Reduced 13.32%
201,931 $578,000
Q2 2022

Aug 12, 2022

SELL
$2.19 - $3.98 $52,071 - $94,632
-23,777 Reduced 9.26%
232,966 $578,000
Q1 2022

May 16, 2022

BUY
$3.28 - $7.12 $246,334 - $534,726
75,102 Added 41.35%
256,743 $983,000
Q4 2021

Feb 14, 2022

SELL
$6.55 - $13.25 $250,131 - $505,991
-38,188 Reduced 17.37%
181,641 $1.21 Million
Q3 2021

Nov 15, 2021

BUY
$7.29 - $11.0 $1.49 Million - $2.24 Million
203,726 Added 1265.14%
219,829 $1.99 Million
Q2 2021

Aug 16, 2021

BUY
$9.87 - $13.32 $158,936 - $214,491
16,103 New
16,103 $188,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $847M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.